Hi, I was diagnosed with recurrent endometrial cancer last year after having a full hysterectomy 11 years ago for Stage 1a.  I had the usual carbo/taxol chemotherapy last summer which was partially successful in reducing the tumours but it took a while for me to recover from that course so I do not wish to repeat it.

I have heard that a combination of Pembrolizumab and Lenvatinib was approved by NICE and NHS last month as a treatment regimen that could double length of survival and may even stabilise the disease.   The downside is that it has bad gastro - intestinal side effects.   

Has any woman been offered this treatment or experienced it as part of a trial?   I would love to know more as I do not wish to unduly compromise my active lifestyle .   Many Thanks.